BRIEF published on 12/13/2024 at 12:02, 4 months 1 day ago Citigroup reduces its stake in GENEURO SA Euronext Paris Sale Of Shares Threshold Crossing GeNeuro SA Citigroup
BRIEF published on 12/06/2024 at 18:35, 4 months 8 days ago GeNeuro's New Precision Medicine for ALS Unveiled Precision Medicine GeNeuro ALS Treatment GNK-301 HERV-K ENV
PRESS RELEASE published on 12/06/2024 at 18:30, 4 months 8 days ago Inside Information / Other news releases GeNeuro presents groundbreaking findings on precision medicine for ALS patients with GNK-301 at the 35th International Symposium on ALS/MND. Research highlights potential of targeting HERV-K ENV to transform ALS treatment Precision Medicine ALS GeNeuro GNK-301 HERV-K ENV
BRIEF published on 11/06/2024 at 09:48, 5 months 8 days ago Crossing of thresholds by Invus Public Equities in GENEURO SA Euronext Paris Capital Increase Crossing Thresholds GeNeuro SA Invus Public Equities
BRIEF published on 06/28/2024 at 07:05, 9 months 16 days ago GeNeuro announces the results of the GNC-501 trial in post-Covid-19 syndrome Business Strategy Clinical Test GeNeuro Temelimab Post-Covid-19 Syndrome
PRESS RELEASE published on 06/28/2024 at 07:00, 9 months 16 days ago Inside Information / Other news releases GeNeuro announces results of the GNC-501 study addressing post-COVID-19 neuropsychiatric syndromes. Initial findings show no significant improvement with temelimab treatment compared to placebo GeNeuro Temelimab Neuropsychiatric Post-Covid-19 Syndrome GNC-501 Study
BRIEF published on 06/14/2024 at 18:35, 10 months ago GeNeuro Announces Unanimous Approval of Resolutions at AGM Shareholders Biopharmaceutical AGM Resolutions GeNeuro
PRESS RELEASE published on 06/14/2024 at 18:30, 10 months ago Inside Information / Other news releases GeNeuro shareholders approve all resolutions proposed at 2024 AGM, including annual report, re-election of Board members, and compensation approval. 81.54% share capital represented at the meeting Shareholders Compensation AGM Resolutions GeNeuro
BRIEF published on 05/29/2024 at 19:32, 10 months 16 days ago GeNeuro: Information on the General Meeting of June 12, 2024 Shareholders Biopharmaceutical Multiple Sclerosis General Assembly GeNeuro
PRESS RELEASE published on 05/29/2024 at 19:27, 10 months 16 days ago Inside Information / Other news releases GeNeuro announces availability of documents for the annual shareholders’ meeting on June 12, 2024 in Geneva, Switzerland. Documents accessible online and at company headquarters Shareholders' Meeting Annual Meeting GeNeuro Geneva Documents Availability
Published on 04/14/2025 at 22:30, 29 minutes ago Bausch Health Announces Adoption of Shareholder Rights Plan
Published on 04/14/2025 at 22:15, 44 minutes ago Kingstone Announces Renewal Rights Transaction to Grow Homeowners Insurance Business in Downstate New York
Published on 04/14/2025 at 18:00, 4 hours 59 minutes ago IEH Corporation to Present at the Planet MicroCap Showcase
Published on 04/14/2025 at 15:20, 7 hours 39 minutes ago MicroVision Attains TISAX Assessment, An Important Achievement in Global Auto Industry
Published on 04/14/2025 at 15:00, 7 hours 59 minutes ago Wi2Wi Corporation Announces Full Year 2024 Financial Results
Published on 04/14/2025 at 20:10, 2 hours 49 minutes ago Morocco sets the stage for Africa’s digital future ahead of continental launchpad event for innovation, Artificial Intelligence (AI) and digital leadership in Marrakech
Published on 04/14/2025 at 19:02, 3 hours 56 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
Published on 04/14/2025 at 18:44, 4 hours 14 minutes ago Rack Centre’s LGS2 12MW Data Centre, gamechanger to revolutionise Nigeria’s Digital Landscape
Published on 04/14/2025 at 18:44, 4 hours 14 minutes ago fox e-mobility AG: Implementation of the Capital Resolutions of the Annual General Meeting -Financial Calendar
Published on 04/14/2025 at 18:04, 4 hours 54 minutes ago Disclosure of trading in own shares between April 7th and April 11th, 2025
Published on 04/14/2025 at 17:45, 5 hours 14 minutes ago PR - Decision of the Board of Directors on April 13, 2025
Published on 04/14/2025 at 17:35, 5 hours 24 minutes ago Disclosure of transactions in own shares from April 7 to April 11, 2025
Published on 04/14/2025 at 08:15, 14 hours 43 minutes ago Aéroports de Paris SA - Filing of the 2024 Universal Registration Document
